当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3781491
自主品牌
已选条件
-
T61229VEGFR-2/DHFR-IN-2；化合物 VEGFR-2/DHFR-IN-2VEGFR-2/DHFR-IN-2
VEGFR-2/DHFR-IN-2 (compound 5b) is a dual inhibitor targeting VEGFR-2 and DHFR, with respective IC50 values of 0.623 μM and 9.085 μM. It demonstrates potent cytotoxicity against C26, HepG2, and MCF7 cancer cell lines, with IC50 values ranging from 3.59 μM to 8.38 μM. VEGFR-2/DHFR-IN-2 holds promise for cancer research [1].
价 格：￥电议型 号：T61229产 地：中国大陆
-
T61183MRGPRX4 modulator-2；化合物 MRGPRX4 modulator-2MRGPRX4 modulator-2
MRGPRX4 modulator-2 (compound 1-55) is a highly potent modulator of MRGPR X4, displaying antagonist activity against this receptor with an IC50 value of less than 100 nM. Its application in the research of autoimmune diseases such as psoriasis, multiple sclerosis, Steven Johnson´s Syndrome, and various chronic itch conditions is notable [1].
价 格：￥电议型 号：T61183产 地：中国大陆
-
T61137VEGFR-2-IN-19；化合物 VEGFR-2-IN-19VEGFR-2-IN-19
VEGFR-2-IN-19 (Compound 15b) is a highly efficacious inhibitor of VEGFR2, a receptor involved in angiogenesis. Its mechanism of action involves the induction of cellular apoptosis and elevation of intracellular reactive oxygen species. Due to these properties, VEGFR-2-IN-19 holds promise as an effective anticancer agent [1].
价 格：￥电议型 号：T61137产 地：中国大陆
-
T61038VEGFR-2-IN-10；化合物 VEGFR-2-IN-10VEGFR-2-IN-10
VEGFR-2-IN-10 has enhanced antiangiogenic potency against VEGFR2 phosphorylation induced by VEGF with an IC50 value of 0.7 μM and no cytotoxic effects.
价 格：￥电议型 号：T61038产 地：中国大陆
-
T60805JNK3 inhibitor-2；化合物 JNK3 inhibitor-2JNK3 inhibitor-2
JNK3 inhibitor-2 is a potent and selective JNK3 inhibitor. The IC50 values of JNK3 inhibitor-2 for JNK1, JNK2, JNK3 are >100, >100, 0.25 μM, respectively. JNK3 inhibitor-2 also inhibits DDR1 and EGFR (T790M, L858R) [1].
价 格：￥电议型 号：T60805产 地：中国大陆
-
T60640SSAO inhibitor-2；化合物 SSAO inhibitor-2SSAO inhibitor-2
SSAO inhibitor-2 (Compound 1) can be used in the research of atherosclerosis, diabetes and its complications, obesity, stroke, chronic kidney disease, retinopathy, chronic obstructive pulmonary disease (COPD), autoimmune diseases, multiple sclerosis, etc. SSAO inhibitor-2 is the inhibitor of semicarbazide-sensitive amine oxidase (SSAO) with IC 50 s <10 nM and 10-100 μM for human SSAO and MAO-A, respectively [1].
价 格：￥电议型 号：T60640产 地：中国大陆
-
T60612Neboglamine hydrochloride；Neboglamine 盐酸盐XY 2401 hydrochloride|||CR-2249 hydrochloride；XY 2401 hydro
Neboglamine hydrochloride (CR-2249 hydrochloride) is an orally active positive modulator of NMDA receptors with neuroprotective activity, enhances cognition, and may be used in studies of schizophrenia and lupus erythematosus.
价 格：￥电议型 号：T60612产 地：中国大陆
-
T60541PCSK9 modulator-2；化合物 PCSK9 modulator-2PCSK9 modulator-2
PCSK9 modulator-2 (Compound 1) is a potent PCSK9 modulator (EC 50 = 202 nM) that has the potential to be used in hyperlipidemia research. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a recently validated therapeutic target for lowering low-density lipoprotein cholesterol (LDL-C) [1].
价 格：￥电议型 号：T60541产 地：中国大陆
-
T60359cis-4-Br-2,5-F2-PCPA；化合物 cis-4-Br-2,5-F2-PCPAcis-4-Br-2,5-F2-PCPA
cis-4-Br-2,5-F2-PCPA (S1024) inhibits LSD1 and LSD2 with Ki values of 94 nM and 8.4 μM, respectively. There is aberrant expression of LSD1 in cancer stem cells, cis-4-Br-2,5-F2-PCPA inhibits LSD1 cell proliferation and by increasing the level of dimethylated histone H3 at K4 (H3K4) in CCRF-CEM cells [1].
价 格：￥电议型 号：T60359产 地：中国大陆
-
T60218YAP/TAZ inhibitor-2u00A0；化合物YAP/TAZ inhibitor-2u00A0YAP/TAZ inhibitor-2u00A0
YAP/TAZ inhibitor-2 is a potent and orally active TEAD-YAP/TAZ inhibitor with an EC 50 value of 3 nM. YAP/TAZ inhibitor-2 shows anti-proliferative and antitumor activity [1].
价 格：￥电议型 号：T60218产 地：中国大陆
-
T60032BRM/BRG1 ATP Inhibitor-2；化合物 BRM/BRG1 ATP Inhibitor-2BRM/BRG1 ATP Inhibitor-2
BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
价 格：￥电议型 号：T60032产 地：中国大陆
-
T5678Lazabemide hydrochloride拉扎贝胺盐酸盐N-(2-Aminoethyl)-5-chlor-2-pyridincarbox|||拉扎贝胺盐酸盐
Lazabemide hydrochloride (N-(2-Aminoethyl)-5-chlor-2-pyridincarbox) is a reversible and selective mao-b inhibitor(Ki：7.9nM).
价 格：￥电议型 号：T5678产 地：中国大陆
-
T5452Ehp-inhibitor-2；化合物Ehp-inhibitorEhp-inhibitor-2
Ehp-inhibitor-2 is an Eph family tyrosine kinase inhibitor targeting Eph receptors.
价 格：￥电议型 号：T5452产 地：中国大陆
-
T50103NFAT Inhibitor-2；化合物 NFAT Inhibitor-2NFAT Inhibitor-2
NFAT Inhibitor-2 is a compound used as a molecular building block.
价 格：￥电议型 号：T50103产 地：中国大陆
-
T4414Eprenetapopt；化合物PRIMA-1MetAPR-246|||PRIMA-1Met；APR-246|||PRIMA-1Met
Eprenetapopt (PRIMA-1Met) restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. PRIMA-1MET also targets the selenoprotein thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance.
价 格：￥电议型 号：T4414产 地：中国大陆
-
T4210SAR-20347；化合物SAR20347SAR20347；SAR20347
SAR-20347 is an inhibitor of TYK2, JAK1/2/3 (IC50: 0.6/23/26/41 nM).
价 格：￥电议型 号：T4210产 地：中国大陆
-
T40581TIE-2/VEGFR-2 kinase-IN-2；TIE-2/VEGFR-2 kinase-IN-2TIE-2/VEGFR-2 kinase-IN-2
TIE-2/VEGFR-2 kinase-IN-2 is a powerful inhibitor of both VEGFR2 and Tie-2 kinases, displaying noteworthy pIC 50 values of 8.61 and 8.56, respectively. This compound acts as an anti-angiogenic agent, making it highly relevant for cancer research.
价 格：￥电议型 号：T40581产 地：中国大陆
-
T39992FGFR1 inhibitor-2FGFR1 inhibitor-2FGFR1 inhibitor-2
FGFR1 inhibitor-2 (with an IC50 of 4.55 μM in MDA-MB-231 cells) is a potent inhibitor of FGFR1. It is specifically useful for studying metastatic triple-negative breast cancer.
价 格：￥电议型 号：T39992产 地：中国大陆
-
T39727ERα degrader-2；ERα降解剂2ERα degrader-2
ERα degrader-2 is a selective and potent estrogen receptor (SERD) degrader with anticancer activity, inhibits ERα, and has an EC50 value for estrogen receptor degradation of 0.3 nM.ERα degrader-2 can be used for the prevention and treatment of HER-positive breast cancer.
价 格：￥电议型 号：T39727产 地：中国大陆
-
T39115ABR-238901；化合物ABR-238901ABR-238901
ABR-238901 is an oral, active S100A8/A9 blocker that inhibits the interaction of S100A8/A9 with its receptors RAGE(receptor for advanced glycation end products) and TLR4 (toll-like receptor 4). ABR-238901 has potential as a compound for the treatment of myocardial infarction (MI).
价 格：￥电议型 号：T39115产 地：中国大陆
